Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma
The clinical management of metastatic urothelial carcinoma (mUC) is undergoing a major paradigm shift; the integration of immune checkpoint inhibitors (ICIs) and antibody–drug conjugates (ADCs) into the mUC therapeutic strategy has succeeded in improving platinum-based chemotherapy outcomes. Given t...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2024-03-01
|
| Serier: | Medicina |
| Fag: | |
| Online adgang: | https://www.mdpi.com/1648-9144/60/4/585 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
